Inhibitor Therapeutics (INTI) Short Interest
OTCPK • INTI • US45720M1053
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 0.3 days to cover, cost to borrow 2.75%. Sign up for live short interest data.
OTCPK • INTI • US45720M1053
As of Oct 28, 2026, ORTEX estimated 0% of free float sold short, 0.3 days to cover, cost to borrow 2.75%. Sign up for live short interest data.
This page tracks how heavily Inhibitor Therapeutics (OTCPK:INTI) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Inhibitor Therapeutics (OTCPK: INTI) has a market capitalization of $13.9M. Last close $0.08 (as of 2026-11-12); 52-week range $0.04 to $0.12. ORTEX data as of 2026-10-28: short interest was 0% of free float, 0.3 days to cover and the average cost to borrow was 2.75%. Sign up for live short interest data.